ARID1A and ovarian carcinoma: Shen et al. reported that tumors formed by an ARID1A-deficient ovarian cancer cell line in syngeneic mice displayed increased mutation load, elevated numbers of tumor-infiltrating lymphocytes, along with PD-L1 expression.